Previous close | 148.09 |
Open | 147.33 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 143.89 - 148.24 |
52-week range | 55.68 - 155.48 |
Volume | |
Avg. volume | 424 |
Market cap | 11.716B |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
A trio of peculiar picks.
The average of price targets set by Wall Street analysts indicates a potential upside of 38% in Sarepta Therapeutics (SRPT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Sarepta Therapeutics (SRPT) have what it takes to be a top stock pick for momentum investors? Let's find out.